## AJG: Arthur J. Gallagher & Co. - XLF: Financial Services

### Executive Summary

No thesis match: MRS_10 -3.9% below STRENGTH zone (3.0-6.0%). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($234.48)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 3
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Choreo LLC Decreases Stake in Arthur J. Gallagher & Co. $AJG**
- Source: MarketBeat | 20251129T140758 | Neutral | Relevance: 99%
- Choreo LLC reduced its stake in Arthur J. Gallagher & Co. by 22.3% in Q2, now holding 10,647 shares valued at $3.41 million. Despite mixed analyst sentiment and recent price target cuts, institutional ownership remains high at 85.53% with some firms increasing their holdings. The company recently announced a quarterly dividend of $0.65 per share but missed its Q3 EPS estimates.

**2. Arthur J. Gallagher (AJG): Evaluating Valuation After Strong Q3 Growth and Tompkins Insurance Acquisition**
- Source: Simply Wall Street | 20251201T043557 | Somewhat-Bullish | Relevance: 98%
- Arthur J. Gallagher (AJG) has continued its strong growth streak with its nineteenth consecutive quarter of double-digit revenue growth and the acquisition of Tompkins Insurance Agencies. Despite this performance and projected undervaluation by some metrics, its high P/E ratio compared to peers raises concerns about potential valuation pressure. The article explores differing valuation perspectives and offers resources for investors to conduct further research.

**3. Palmetto Grain Brokerage -**
- Source: Palmetto Grain Brokerage | 20251201T070646 | Neutral | Relevance: 72%
- Marsh & McLennan (MMC) stock has significantly underperformed the financial sector and its peer, Arthur J. Gallagher & Co. (AJG), despite strong Q3 revenue and EPS growth and strategic initiatives like rebranding and share buybacks. The company reported an 11% year-over-year revenue increase in Q3, reaching $6.4 billion, and an 11% rise in adjusted EPS to $1.85. Analysts, however, maintain a "Moderate Buy" rating with a potential upside of 16.3%.

### Analyst Activity

**Target Signal:** BEARISH (Raises: 0, Lowers: 2)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-05 | Wells Fargo | $344 | $362 | -5% |
| 2025-11-20 | Barclays | $250 | $328 | -24% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-05 | Wells Fargo | main | Overweight |
| 2025-11-20 | Barclays | down | Underweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 3 ($0.55M) |
| Sells | 4 ($3.29M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 57.4% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 2 |

**Top Holders:**
- JPMORGAN CHASE & CO: 15.8% (+139.2%)
- Vanguard Group Inc: 12.1% (+0.2%)
- Blackrock Inc.: 7.2% (-2.2%)
- FMR, LLC: 4.9% (-4.1%)
- Capital World Invest: 4.6% (+0.9%)

### Key Risks

1. Insider selling cluster: $3.3M in recent transactions.
2. Long-term trend broken: trading 20.2% below SMA200.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 0.79 indicates undervaluation relative to growth. Forward P/E 18.3x attractive for 24% earnings growth. Revenue growth strong at 21% YoY. Analyst sentiment negative (2 target cuts vs 0 raises). Insider selling cluster ($3.3M in 90 days), potential headwind. Institutional flow bullish (7 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $61.7B |
| Beta | 0.69 |
| 52W Range | $236.37 - $351.23 |
| Short Interest | 1.9% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.79 |
| Forward P/E | 18.3 |
| Current P/E | 22.7 |
| YoY Growth | 23.9% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from -2.8% to -3.9% (-1.2% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 6.9pp (needs >3.0% for momentum thesis). Underperforming sector by 3.8pp, stock-specific weakness. Below SMA200 (0.80x), long-term trend not supportive. MACD histogram positive (0.86), confirming momentum.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -3.93% (CS: 7) | Weak |
| RSI_14 | 34.4 | Neutral |
| MACD Histogram | 0.86 | Bullish |
| vs SMA20 | 0.980x | Below |
| vs SMA50 | 0.892x | Below |
| vs SMA200 | 0.798x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $246.10
- **Stop Loss:** $234.48 (4.7% risk)
- **Target:** $257.72 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 86
- **Position Value:** $21,164.60
- **Portfolio %:** 21.16%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

### Earnings

**Next:** 2026-01-29 (Est: $2.49)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.54 | $2.32 | -8.5% |
| 2025Q2 | $2.34 | $2.33 | -0.6% |
| 2025Q1 | $3.58 | $3.67 | +2.5% |
| 2024Q4 | $2.03 | $2.13 | +5.0% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_10*